NRX Pharmaceuticals (NRXP) Interest Coverage Ratio (QoQ) (2020 - 2024)
NRX Pharmaceuticals (NRXP) Interest Coverage Ratio (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | NRX Pharmaceuticals | 117.34 Mn | 110.64 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 70.88% |
| Dec 31, 2023 | -374.13% |
| Sep 30, 2023 | 93.47% |
| Jun 30, 2023 | -473.75% |
| Mar 31, 2023 | -699.76% |
| Dec 31, 2022 | 88.20% |
| Sep 30, 2022 | 40.40% |
| Jun 30, 2022 | -253.41% |
| Mar 31, 2022 | 99.94% |
| Dec 31, 2021 | -1,640,325.21% |
| Sep 30, 2021 | -93.93% |
| Jun 30, 2021 | 1.18% |
| Mar 31, 2021 | 99.90% |
| Dec 31, 2020 | -95.81% |
| Sep 30, 2020 | -1,094.04% |